Persei vivarium was invited to the launch of “The Nest – Innovative Solutions Challenge”, an accelerated program powered by Takeda and Impact Hub for innovative projects developing initiatives and solutions to improve the quality of life for oncology patients or those with intestinal disease. The objective of the program is to provide technical support and boost the creation of specialized startups in the health sector in this country.
Persei vivarium has extensive experience in projects related to intestinal diseases, which is why our CEO, Roberto Bravo and CTO, Miguel Cabañas, attended the presentation of the program that was held on Friday, March 2 in Madrid.
Takeda is a pharmaceutical laboratory that operates around the world, driven by innovation and focused on patients. It has a solid 235-year history, and aims to provide better health and a brighter future for everyone.
Impact Hub is a global network of people, spaces and programs that inspire, connect and work to generate a positive impact on society.